Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.270
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
4.390
+0.120 (2.80%)
After-hours: Dec 5, 2025, 7:18 PM EST
Neuphoria Therapeutics Revenue
Neuphoria Therapeutics had revenue of $15.65M in the twelve months ending September 30, 2025. In the fiscal year ending June 30, 2025, Neuphoria Therapeutics had annual revenue of $15.65M.
Revenue (ttm)
$15.65M
Revenue Growth
n/a
P/S Ratio
0.51
Revenue / Employee
$1,956,181
Employees
8
Market Cap
22.96M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NEUP News
- 2 days ago - Neuphoria Responds to Lynx1's Revised Indication of Interest at a Reduced Price and Premium - GlobeNewsWire
- 5 days ago - Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions - GlobeNewsWire
- 12 days ago - Neuphoria Therapeutics Inc. Sends Letter to Stockholders - GlobeNewsWire
- 25 days ago - Neuphoria Announces Initiation of Strategic Review to Maximize Stockholder Value - GlobeNewsWire
- 5 weeks ago - Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process - GlobeNewsWire
- 6 weeks ago - PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
- 6 weeks ago - Neuphoria Therapeutics Provides Update on AFFIRM-1 Phase 3 Trial Evaluating BNC210 for the Acute Treatment of Social Anxiety Disorder - GlobeNewsWire
- 2 months ago - Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates - GlobeNewsWire